Research and Markets: World Cancer Diagnostics Market 2015-2019
November 30 2015 - 4:14AM
Business Wire
Research and Markets
(http://www.researchandmarkets.com/research/pbvn8h/20152019_world)
has announced the addition of the "2015-2019 World Cancer
Diagnostics Market: Supplier Shares, Country Forecasts, Innovative
Technologies, Competitive Strategies--France, Germany, Italy,
Japan, Spain, UK, US" report to their offering.
This new report is a study of the major business opportunities
emerging in the global cancer diagnostics market during the
next five years. The report examines trends in the U.S.,
Europe and Asia; reviews current and emerging assays; analyzes
potential applications of new diagnostic technologies; forecasts
sales of major tumor markers by country and market segment;
profiles leading players and potential market entrants; and
identifies specific business opportunities for suppliers.
The cancer diagnostics market is on the verge of explosion, as
the researchers approach major technological breakthroughs in tumor
diagnosis and therapy, discover new specific antigens, and unlock
the mystery of the genetic basis of the disease. During the next
five years, the worldwide cancer diagnostics market is promising to
be an exciting, dynamic and rapidly expanding field.
Anticipated technological breakthroughs will create numerous
opportunities for determining genetic predisposition, detecting
specific tumors, and monitoring biological response to cancer
therapy. The rise in geriatric population will further compound the
growing demand for malignancy assays and the rapid market expansion
worldwide.
Scope of the Report:
Geographic Coverage:
- France
- Germany
- Italy
- Japan
- Spain
- UK
- USA
Worldwide Market Overview:
- Five-year test volume and sales projections by country.
- Comprehensive market segmentation analysis, including review of
the market dynamics, structure, size, growth and major suppliers by
country.
- Estimated universe of laboratories performing cancer diagnostic
testing by country.
- Cancer statistics, etiology and recent developments in the
U.S., Europe and Asia.
Business Opportunities and Strategic Recommendations:
- Specific new product development opportunities with potentially
significant market appeal during the next five years.
- Design criteria for new products.
- Alternative market penetration strategies.
- Potential market entry barriers and risks.
30 of over 50+ companies mentioned:
- Abbott
- AdnaGen
- Agilent Technologies
- Applied Gene Technologies
- Arca BioPharma
- Beckman Coulter/Danaher
- Becton Dickinson
- Biomedical Diagnostics
- bioMerieux
- Bio-Rad
- CellSearch
- Cepheid
- Correlogic Systems/Vermillion
- Decode Genetics
- Diadexus
- Diagnocure
- DiaSorin
- Eiken Chemical
- Elitech Group
- Epigenomics
- Enterix
- Enzo Biochem
- Exact Sciences
- Fujirebio
- Guided Therapeutics
- Hologic/Gen-Probe
- Kreatech/Leica
- Kyowa Medex
- Mackay Life Sciences
- Myriad Genetics
For more information visit
http://www.researchandmarkets.com/research/pbvn8h/20152019_world
View source
version on businesswire.com: http://www.businesswire.com/news/home/20151130005413/en/
Research and MarketsLaura Wood, Senior
Managerpress@researchandmarkets.comFor E.S.T Office Hours Call
1-917-300-0470For U.S./CAN Toll Free Call 1-800-526-8630For GMT
Office Hours Call +353-1-416-8900U.S. Fax: 646-607-1907Fax (outside
U.S.): +353-1-481-1716Sector: Diagnostics